Varenicline for Treatment of E-cigarette Dependence
Status:
Not yet recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Varenicline is used to treat tobacco use dependence. It helps reduce cravings for tobacco use
and decreases the pleasurable effects of cigarettes and other tobacco products. Varenicline
has been proven to reduce the desire to smoke cigarettes. This study aims to test whether it
shows a similar benefit for individuals who vape and are interested in quitting.